Every 45 minutes, a man in the UK dies from prostate cancer. That statistic, from Prostate Cancer UK, is the cold arithmetic behind Ella Toone’s decision to become an ambassador for the charity. Her father Nick died of the disease in 2024, three days short of his 60th birthday.
He was diagnosed the day after he watched his daughter score in the Euro 2022 final. Toone is a Lioness.
She won the European championships in 2022 and again in 2025. But the loss of her father, whom she called her “absolute hero” and the reason she plays for England, has pulled her into a different fight. Prostate cancer is now the UK’s most common cancer.
One in eight men will get it. The numbers are blunt, and they are rising.
The charity is the UK’s biggest public funder of prostate cancer research. Its work focuses on making screening a reality and giving men treatment options with fewer side effects. Toone’s role as ambassador puts a public face on that mission.
She is not a researcher or a doctor. She is a footballer whose family was hit by a disease that, statistically, is hitting more families every year. Nick Toone’s diagnosis came late.
He watched his daughter score at Wembley in the Euro 2022 final, a match England won 2-1 against Germany. The next day, he learned he had prostate cancer.
He died two years later. That timeline is not unusual. Prostate cancer often shows no symptoms until it has spread.
Screening is not routine. The charity is pushing to change that.
What matters now is what happens next. Toone’s profile gives Prostate Cancer UK a voice in locker rooms and living rooms where the disease might not otherwise get discussed. Men in their 50s and 60s, the group most at risk, may hear the message differently when it comes from a Lioness who lost her father at 59.
The charity needs that. Research funding depends on awareness. Awareness depends on people willing to talk openly about a disease that men often avoid mentioning.
Toone has talked openly. She said her father was the reason she is a Lioness.
That personal connection is the core of her ambassador role. It is not abstract. It is a daughter who watched her father die three days before his 60th birthday.
The wider picture, according to the charity, is one of hope. Research is advancing.
Treatment options are improving. But the clock is running. One man dies every 45 minutes.
That is 32 men a day. Over a year, it is more than 11,000. Those numbers will not drop without sustained effort.
Toone’s appointment is one piece of that effort. It will not cure anyone by itself.
But it puts a familiar face on a disease that, for many, remains something they do not discuss until it is too late. Her father’s story is a reason to talk earlier. That is the point.
